12-05-2021 | Oncology | Highlight | Article
COVID-19 leaves large cancer screening deficit in USA
Breast, prostate, and colorectal cancer screening rates declined sharply during the initial months of the COVID-19 pandemic in the USA, and while they subsequently recovered, a large deficit remains, study findings indicate.
16-02-2021 | Oncology | News | Article
LuPSMA ‘promising alternative’ to cabazitaxel in mCRPC
The radiolabeled small molecule lutetium-177-prostate-specific membrane antigen-617 offers higher activity and better patient-reported outcomes than cabazitaxel in metastatic castration-resistant prostate cancer, research shows.
USA outline_flag/© Image by Gordon Johnson from Pixabay, Older man_chest pain (symbolic image with models)/© nd3000 / Getty Images / iStock